HIV Integrase Inhibitor

DB16114InvestigationalSmall molecule

HIV Integrase Inhibitor is under investigation in clinical trial NCT00397566 (A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects).

Mechanism: Pharmacologically active on Gag-Pol polyprotein
Curator reviewed
Formula / weight: C₁₇H₁₉FN₄O₅S · 410.42 g/mol (avg)
Code names: BMS-707035

Resolves to

Compound

UNII7PR4P7YOKTCAS729607-74-3ChEMBLCHEMBL486226

Structure

InChIKeyVNIWZCGZPBJWBI-UHFFFAOYSA-NSMILESCN1C(=O)C(O)=C(N=C1N1CCCCS1(=O)=O)C(=O)NCC1=CC=C(F)C=C1

Targets

Q7ZJM1pol

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with HIV Integrase Inhibitor, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account